MoneyWorks4Me

Sequent Scientific - Quaterly Results

10 Aug 2023 Evaluate
A decrease of about -37.68% in the sales to Rs. 404.23 millions was observed for the quarter ended June 2023. The sales stood at Rs. 648.60 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2023 is Rs. -68.03 millions as compared to Net Profit of Rs. 8.40 millions of corresponding quarter ended June 2022The Operating Profit of the company witnessed a decrease to 6.28 millions from 38.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 404.23 648.60 -37.68 404.23 648.60 -37.68 2226.85 2196.26 1.39
Other Income 96.95 58.80 64.88 96.95 58.80 64.88 282.42 276.43 2.17
PBIDT 6.28 38.90 -83.86 6.28 38.90 -83.86 18.82 268.93 -93.00
Interest 9.82 3.54 177.40 9.82 3.54 177.40 25.13 16.10 56.09
PBDT -66.08 35.36 -286.88 -66.08 35.36 -286.88 -6.31 252.83 -102.50
Depreciation 24.25 23.81 1.85 24.25 23.81 1.85 91.15 95.93 -4.98
PBT -90.33 11.55 -882.08 -90.33 11.55 -882.08 -97.46 156.90 -162.12
TAX -22.30 3.15 -807.94 -22.30 3.15 -807.94 -36.66 8.91 -511.45
Deferred Tax -7.28 1.05 -793.33 -7.28 1.05 -793.33 -30.94 5.20 -695.00
PAT -68.03 8.40 -909.88 -68.03 8.40 -909.88 -60.80 147.99 -141.08
Equity 498.87 498.87 0.00 498.87 498.87 0.00 498.87 496.74 0.43
PBIDTM(%) 1.55 6.00 -74.10 1.55 6.00 -74.10 0.85 12.24 -93.10
Peers
Company Name CMP
Sun Pharma. Inds. 1846.20
Dr. Reddys Labs. 1208.25
Cipla 1367.10
Lupin 2114.70
Zydus Lifesciences 1163.85
View more..